abstract |
The present invention provides novel aminobenzazoles and analogs thereof that are selective inhibitors of the human P2Y 1 receptor. The present invention also provides various pharmaceutical compositions and methods for treating diseases that respond to modulation of P2Y 1 receptor activity. |